Skip to main content

6 Result(s)

within R Mick Remove this filter

and

  1. No Access

    Article

    Classifying ultra-high risk smoldering myeloma

    A J Waxman, R Mick, A L Garfall, A Cohen, D T Vogl, E A Stadtmauer, B M Weiss in Leukemia (2015)

  2. No Access

    Article

    Association between mobilization regimen and PFS after auto-SCT for multiple myeloma

    A L Garfall, A L Dougherty, D T Vogl, B M Weiss, A D Cohen… in Bone Marrow Transplantation (2014)

  3. No Access

    Article

    Performance and quality of life outcome in patients completing concomitant chemoradiotherapy protocols for head and neck cancer

    This study evaluated post-treatment performance and quality of life (QOL) outcome in head and neck cancer (HNC) patients treated with organ preservat ion, intens ive chemoradiotherapy (FHX). Participants were ...

    M. A. List, P. Mumby, D. Haraf, A. Siston, R. Mick… in Quality of Life Research (1997)

  4. No Access

    Chapter and Conference Paper

    A Phase II trial of induction Cisplatin, 5-FU, Leucovorin, and Interferon α-2B (PFL-α) followed by concurrent Hydroxyurea, 5-FU and radiation for Stage IV squamous cell cancers of the head and neck (HNC)

    The combination of Cisplatin and Infusional fluorouracil has been widely used for the treatment of locally advanced squamous head and neck cancer, at diagnosis and recurrence [1–4]. When applied in the Neo-Adj...

    M. S. Kies, D. J. Haraf, B. Mittal, I. Athanasiadis… in Cancer Treatment An Update (1994)

  5. No Access

    Article

    A randomised study comparing intermittent to continuous administration of magnesium aspartate hydrochloride in cisplatin-induced hypomagnesaemia

    EE Vokes, R Mick, NJ Vogelzang, R Geiser, F Douglas in British Journal of Cancer (1990)

  6. No Access

    Article

    Programmierte Geburt

    H. Steiner, H. -G. Hillemanns, H. J. Krüger, R. Rasenack… in Archives of gynecology (1979)